Cliantha Research | Full Service CRO
loader
award slider

Success StoryCEO of the Year
IAE Awards London

LEARN MORE
slider1

Our Scientists have more than 10 years of Experience

LEARN MORE
slider2

Method Development for complex analytes and endogenous compounds

LEARN MORE
slider3

Biospecimen Storage of up to1 Million Samples

LEARN MORE
slider4

PK Analysis - under GLP in all matrices

LEARN MORE
slider6

High Quality, Accurate and Reproducible Results for Global Submissions

LEARN MORE

About Cliantha Canada

Hill Top Research ULC d/b/a Cliantha Research is a Bioanalytical Laboratory and Biospecimen Storage facility. The laboratory is a subsidiary of Cliantha Research Limited, a global full service Contract Research Organization (CRO) with integrated offerings in Clinical (Phase I, II, III and IV), Bioanalytical, Dermatology, Biometrics, Bioavailability and Bioequivalence (BA/BE), Biosimilars, and Personal Healthcare services.

Our Toronto Bioanalytical Lab began operations in 2013. Integrity in the science is the foundation of the research conducted at the site. This enables the lab to produce high quality, accurate results from human and animal pharmacokinetic (PK) samples. We achieve this by our team of experts. The Cliantha team of scientists leading the operations has more than 15 years of experience each and our scientists have no less than 10 years of industry experience.

Cliantha Canada provides short- to long-term biospecimen storage. We have the appropriate SOPs and procedures needed to store your samples in a cGLP manner. We ensure your samples are maintained in full compliance at all times.

Cliantha Research Limited facilities have been inspected and audited by global regulatory bodies like FDA, ANSM (France), MCC (South Africa), AGES (Austria), AEMPS (Spain), WHO, MHRA (United Kingdom), Thai MoPH, MOH Turkey, ANVISA (Brazil), Health Canada (SCC) and also many international companies. We have successfully conducted and executed over 5000 studies globally and we have analyzed over 3 million samples.

Regulatory Inspections

Last Inspection in Nov 2015
Inspected facility in Nov 2006
Inspected facility in Jan 2009
Last inspection in Apr-May 2016
Inspected facility in Feb - Mar 2013
Last inspection in June 2018 (4 times)
Inspected facility in July 2013
Last inspected by Ministry of Health of Turkey in April 2013
Last inspection in Apr-May 2016

News & Events

30-3 Jul - Aug
2018

Successful completion of an unannounced USFDA audit

Cliantha has successfully completed its unannounced 5-day comprehensive USFDA inspection from 30 July to 3 August 2018 at...

Learn More
5 July
2018

Young Learning Leader Award

Training & development acts as a catalyst in being competitive. Cliantha Research is one of the few CROs conducting such training...

Learn More
25-29 June
2018

WHO Inspection @ Cliantha Ahmedabad

We feel proud in sharing that WHO inspection (Clinical & Bio-analytical) at Cliantha Research's HQ and...

Learn More
20-22 June
2018

Meet us at CPhI China 2018

Meet us at CPhI China 2018 on June 20-22, 2018 at Shanghai. If you are attending and would like to meet, please contact our representatives...

Learn More
26-30 May
2018

Meet us at EAACI 2018

We welcome the opportunity to talk about allergy-related studies with our industry colleagues at European Academy of Allergy and Clinical Immunology - EAACI 2018 on 26-30 May...

Learn More
23 May
2018

Mr. Naveen Sharma wins CEO OF THE YEAR AWARD

Mr. Naveen Sharma, President - Cliantha Research Limited has recently earned the honourable CEO OF THE YEAR AWARD at the IAE (International Award of Excellence) Pharma...

Learn More
2-5 March
2018

Meet the Inflamax Research team

Meet the Inflamax Research team at WAC 2018 AAAAI WAO Joint Congress by American Academy of Allergy, Asthma, and Immunology & World Allergy Organization in Orlando, FL...

Learn More
27 Feb
2018

Dr. Chirag Shah at 12th Biosimilars Congregation 2018.

Dr. Chirag Shah, Director - Late Phase Trials will speak on "Regulatory considerations in Clinical Study Design of Biosimilars" at 12th...

Learn More
9 Jan
2018

NJ Tobacco Research Amendment Signed into Law!

Today, after 24 months of Hill Top / Inflamax Research working with legislators and special interest groups in New Jersey,Governor Chris Christie signed Assembly Bill A39...

Learn More
21 Apr
2017

Cliantha Research acquires Inflamax Research

Cliantha Research is proud to announce the acquisition of Inflamax Research. Inflamax has locations in Toronto, ON, Neptune, NJ and Newark, NJ...

Learn More
20-23 March
2017

Cliantha at DCAT 2017

Cliantha will be attending DCAT once again. Our senior leaders Naveen Sharma, John Capicchioni and Rahul Nijhawan will be in attendance. They are looking forward to meeting with you...

Learn More
1 March
2017

Hill Top Research has successfully completed FDA inspection

USFDA inspection of Hill Top Research Inc. was conducted at our St. Petersburg, Florida site from Feb 22, 2017 to Mar 01, 2017...

Learn More
21 Feb
2017

Lecture & Panel Discussion at APA-India 2017

Dr. Shaifali Gupta, Laboratory Director, spoke on Biosimilars Bioanalysis: Challenges and Solutions at APA- India 2017 on 21 February’17 at Ahmedabad, India...

Learn More
20 Feb
2017

Poster presentation at APA-India 2017

Mr. Soumen Chakraborty presented a poster on “Bioanalytical Challenges in developing and validating a biomarker assay...

Learn More

Case Studies

Biosimilars Case Studies

Learn More

Nitroglycerine Study

Learn More

Potassium Chloride KCL study

Learn More